Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 17/20 | 0.38 |
| ▸ | MAOA | P21397 | 16/20 | 0.38 |
| ▸ | MAOB | P27338 | 16/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.34 |
| ▸ | HTR2C | P28335 | 2/20 | 0.34 |
| ▸ | HTR2B | P41595 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29806042 | 0.89 | — | — | |
| SCHEMBL1153469 | 0.83 | KDM1A (0.44) | KDM1AMAOAMAOBHTR2AHTR2C | |
| SCHEMBL9100196 | 0.82 | KDM1A (0.34) | KDM1AMAOAMAOBHTR2AHTR2C | |
| SCHEMBL5149443 | 0.82 | HTR2A (0.39) | KDM1AMAOAMAOBHTR2AHTR2C | |
| SCHEMBL365626 | 0.81 | CHRNA7 (0.32) | — | |
| SCHEMBL2870312 | 0.80 | MAOA (0.39) | KDM1AMAOAMAOBHTR2AHTR2C | |
| SCHEMBL20839329 | 0.77 | MAOA (0.32) | KDM1AMAOAMAOB | |
| SCHEMBL31716197 | 0.77 | CUL4A (0.35) | KDM1AMAOAMAOB | |
| SCHEMBL5458200 | 0.77 | — | — | |
| SCHEMBL6984232 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115948022-A | Prepreg, circuit board and printed circuit board | 浙江华正新材料股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-107709424-B | Systems and methods for producing aerogel materials | 气凝胶科技有限责任公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-3029041-B1 | INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA | ICOS CORP (US) | 2020-03-04 | — | — | EP | disclosed |
| US-20200061062-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | ICOS CORPORATION | 2020-02-27 | — | — | US | disclosed |
| US-10398695-B2 | Inhibitors of human phosphatidylinositol 3-kinase delta | ICOS CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
| US-20180360832-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | ICOS CORPORATION | 2018-12-20 | — | — | US | disclosed |
| US-10010550-B2 | Inhibitors of human phosphatidylinositol 3-kinase delta | ICOS CORPORATION (US) | 2018-07-03 | — | — | US | disclosed |
| US-20170340633-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | ICOS CORPORATION | 2017-11-30 | — | — | US | disclosed |
| EP-3159737-A1 | LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT | Nissan Chemical Industries, Ltd. (JP) | 2017-04-26 | — | — | EP | disclosed |
| US-20170049772-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | ICOS CORPORATION | 2017-02-23 | — | — | US | disclosed |
| US-20020161014-A1 | Purinyl substituted quinazoline-4-one derivatives | ICOS CORPORATION, A DELAWARE CORPORATION | 2002-10-31 | — | — | US | disclosed |
| WO-2001081346-A2 | INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA | ICOS CORPORATION (US) | 2001-11-01 | — | — | WO | disclosed |
| US-5347019-A | REACTING 4-HALONAPHTHALIC ANHYDRIDES WITH 2-AMINOTHIOPHENOLATES | CASSELLA AG (DE) | 1994-09-13 | — | — | US | disclosed |
| EP-0270665-A4 | SOLVENTLESS POLYURETHANE SPRAY COMPOSITIONS AND METHOD FOR APPLYING THEM. | AMERON INC (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0270665-A1 | SOLVENTLESS POLYURETHANE SPRAY COMPOSITIONS AND METHOD FOR APPLYING THEM | AMERON, INC. (US) | 1988-06-15 | — | — | EP | disclosed |
| WO-1987007287-A1 | SOLVENTLESS POLYURETHANE SPRAY COMPOSITIONS AND METHOD FOR APPLYING THEM | AMERON, INC. (US) | 1987-12-03 | — | — | WO | disclosed |
| US-4695618-A | Solventless polyurethane spray compositions and method for applying them | AMERON, INC. (US) | 1987-09-22 | — | — | US | disclosed |
| US-4369318-A | USING A BENZO-OR PYRIDO-CINNOLINES AS BLEACH CATALYST | CIBA-GEIGY LTD. (CH) | 1983-01-18 | — | — | US | disclosed |
| US-4266011-A | FUSED PYRIDAZINE CATALYST | CIBA-GEIGY AG (CH) | 1981-05-05 | — | — | US | disclosed |
| US-4008254-A | Ceria catalyzed conversion of phenols to dibenzofurans in the presence of water vapor | MONSANTO COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170340633-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | PIK3CD, PIK3CA, PIK3CG | KDM1A 2892/4885MAOA 4472/4885MAOB 4415/4885 |
| US-20180360832-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | PIK3CD, PIK3CA, PIK3CG | KDM1A 2892/4885MAOA 4472/4885MAOB 4415/4885 |
| US-20020161014-A1 | Purinyl substituted quinazoline-4-one derivatives | PIK3CD, PIK3CA, PIK3CG | KDM1A 3109/4885MAOA 3760/4885MAOB 4002/4885 |
| US-20170049772-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | PIK3CD, PIK3CA, PIK3CG | KDM1A 3066/4885MAOA 4624/4885MAOB 4555/4885 |
| US-20200061062-A1 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | PIK3CD, PIK3CA, PIK3CG | KDM1A 2892/4885MAOA 4472/4885MAOB 4415/4885 |
| US-10010550-B2 | Inhibitors of human phosphatidylinositol 3-kinase delta | PIK3CD, PIK3CA, PIK3CG | KDM1A 2892/4885MAOA 4472/4885MAOB 4415/4885 |
| US-10398695-B2 | Inhibitors of human phosphatidylinositol 3-kinase delta | PIK3CD, PIK3CA, PIK3CG | KDM1A 2892/4885MAOA 4472/4885MAOB 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.